Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biallelic DICER1 mutations occur in Wilms tumours.

The Journal of pathology·2013
Same author

ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.

Oncogene·2013
Same author

Ischemic postconditioning protects against focal cerebral ischemia by inhibiting brain inflammation while attenuating peripheral lymphopenia in mice.

Neuroscience·2013
Same author

Fast-track surgery improves postoperative recovery in patients undergoing partial hepatectomy for primary liver cancer: A prospective randomized controlled trial.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2013
Same author

Snacking may improve physical function among older Americans.

The journal of nutrition, health & aging·2013
Same author

Downregulation of 14-3-3β and 14-3-3ζ in lesions of psoriasis vulgaris.

Clinical and experimental dermatology·2013

Related Experiment Video

Updated: Mar 1, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.3K

Elevated NDC80 expression is associated with poor prognosis in osteosarcoma patients.

B Xu1, D-P Wu, R-T Xie

  • 1Department of Orthopedics, Shandong Energy Zaozhuang Mining Group Center Hospital, Shandong, China. yyxxbb8904@163.com.

European Review for Medical and Pharmacological Sciences
|May 25, 2017
PubMed
Summary

Nuclear division cycle 80 (NDC80) is overexpressed in osteosarcoma (OS) and linked to poorer patient survival. High NDC80 expression may serve as a prognostic biomarker for OS, guiding treatment decisions.

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

877
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.4K

Related Experiment Videos

Last Updated: Mar 1, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.3K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

877
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.4K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Osteosarcoma (OS) is a primary bone cancer affecting children and adolescents.
  • Nuclear division cycle 80 (NDC80), a cell division regulator, is implicated as an oncoprotein in various cancers.
  • The role of NDC80 in OS pathogenesis and prognosis is not well understood.

Purpose of the Study:

  • To investigate the correlation between NDC80 expression and clinicopathological features in OS patients.
  • To evaluate NDC80 as a prognostic biomarker for osteosarcoma.

Main Methods:

  • NDC80 expression analysis in various sarcomas using the Oncomine Platform.
  • Quantitative RT-PCR to measure NDC80 mRNA in 26 paired OS and normal samples.
  • Immunohistochemical analysis of NDC80 in a cohort of 154 OS patients.

Main Results:

  • NDC80 mRNA was significantly overexpressed in OS and other sarcomas (liposarcoma, myxofibrosarcoma, leiomyosarcoma).
  • High NDC80 expression correlated with advanced TNM stage and distant metastasis in OS patients.
  • Elevated NDC80 levels were associated with significantly worse OS-specific and disease-free survival.

Conclusions:

  • NDC80 is clinically significant in OS, showing overexpression and association with poor prognosis.
  • NDC80 may serve as a valuable prognostic biomarker for predicting outcomes in osteosarcoma patients.
  • Targeting NDC80 could offer potential therapeutic strategies and improve treatment decisions for OS.